Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices 1697 

III. Comments 

Interested persons may submit to the 

Division of Dockets Management (see 

ADDRESSES) written or electronic 

comments regarding this document. 

Submit a single copy of electronic 

comments or two paper copies of any 

mailed comments, except that 

individuals may submit one paper copy. 

Comments are to be identified with the 

docket number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

Please note that on January 15, 2008, 

the FDA Division of Dockets 

Management Web site transitioned to 

the Federal Dockets Management 

System (FDMS). FDMS is a 

Government-wide, electronic docket 

management system. Electronic 

comments or submissions will be 

accepted by FDA only through FDMS at 

http://www.regulations.gov. 

Dated: January 6, 2009. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E9–450 Filed 1–12–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 

Comment Request; Follow-up of 

Kidney Cancer Patients From the 

Central European Multicenter CaseControl Study (CEERCC) (NCI) 

SUMMARY: Under the provisions of 

section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Cancer Institute (NCI), the National 

Institutes of Health (NIH), has submitted 

to the Office of Management and Budget 

(OMB) a request to review and approve 

the information collection listed below. 

This proposed information collection 

was previously published in the Federal 

Register on November 3, 2008 (Volume 

73, No. 213, p. 65387) and allowed 60 

days for public comment. There was one 

public comment received which 

questioned why U.S. tax dollars are 

being spent on a study located in 

Europe. The investigator responded 

directly to the comment on 12/19/08 

stating that this study costs less money 

to conduct in central Europe than in the 

U.S. since previous data has already 

been collected. Additionally, since this 

region has the highest rates of kidney 

cancer in the world a study in this area 

would provide a wealth of data in terms 

of the causes of kidney cancer. The 

purpose of this notice is to allow an 

additional 30 days for public comment. 

The National Institutes of Health may 

not conduct or sponsor, and the 

respondent is not required to respond 

to, an information collection that has 

been extended, revised, or implemented 

on or after October 1, 1995, unless it 

displays a currently valid OMB control 

number. 

Proposed Collection: Title: Follow-up 

of Kidney Cancer Patients from the 

Central European Multicenter CaseControl Study (NCI). Type of 

Information Collection Request: New. 

Need and Use of Information Collection: 

The purpose of this questionnaire is to 

obtain information on the 5-year 

survival status of kidney cancer patients 

that were previously enrolled in a 

Central European Case-Control Study of 

Kidney Cancer that was conducted from 

2001 to 2004. The aim is to assess 

survival, the prevalence of recurrent 

disease and progression, and to 

investigate patient, tumor and genetic 

determinants of survival among cases. 

The questionnaire will collect 

information on patient related factors, 

tumor related factors that were not 

collected during the initial study, and 

the type of treatment(s) received since 

the patients were last contacted for the 

case-control study. This questionnaire 

adheres to The Public Health Service 

Act, section 412 (42 U.S.C. 285a–1) and 

section 413 (42 U.S.C. 285a–2), which 

authorizes the Division of Cancer 

Epidemiology and Genetics of the 

National Cancer Institute (NCI) to 

establish and support programs for the 

detection, diagnosis, prevention and 

treatment of cancer; and to collect, 

identify, analyze and disseminate 

information on cancer research, 

diagnosis, prevention and treatment. 

Frequency of Response: Once. Affected 

Public: Individuals. Type of 

Respondents: Individuals that 

participated in the Central European 

Renal Cancer Case-Control Study 

between 2001–2004 and physician 

abstractors. The estimated total annual 

burden hours requested is 296. The 

annualized cost to respondents is 

estimated at $5174. The data will be 

collected within a two-year period. 

There are no additional capital costs, 

operating costs, and/or maintenance 

costs to report. 

ESTIMATES OF ANNUAL BURDEN HOURS

Type of respondents Number of 

respondents 

Frequency 

of response 

Average 

time per 

response 

(Minutes/ 

Hour) 

Annual 

burden 

hours 

Patients ............................................................................................................................ 200 1 40/60 133.33 

Families (NOK) ................................................................................................................ 240 1 40/60 160.00 

Physicians ........................................................................................................................ 10 1 15/60 2.50 

Totals ........................................................................................................................ 450 .................... .................... 295.83 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the function of the 

agency, including whether the 

information will have practical utility; 

(2) The accuracy of the agency’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) Ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

Ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

1698 Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the 

Attention: NIH Desk Officer, Office of 

Management and Budget, at 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and instruments, contact Lee E. 

Moore, PhD, MPH, Investigator, 

Occupational and Environmental 

Epidemiology Branch, Division of 

Cancer Epidemiology and Genetics, 

National Cancer Institute, NIH, DHHS, 

Executive Plaza South, Room 8102, 

6120 Executive Blvd., EPS–MSC 7242, 

Bethesda, MD 20892–7270 or call nontoll-free number 301–496–6427 or email your request, including your 

address to: moorele@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30 days of the date of 

this publication. 

Dated: January 2, 2009. 

Vivian Horovitch-Kelley, 

NCI Project Clearance Liaison Office, 

National Institutes of Health. 

[FR Doc. E9–484 Filed 1–12–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Biological Testing 

Facility (RFP–NIH–NICHD–CPR–09–05). 

Date: February 9, 2009. 

Time: 10 a.m. to 1 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Room 5B01, Rockville, 

MD 20852 (Telephone Conference Call). 

Contact Person: Sathasiva B. Kandasamy, 

PhD, Scientific Review Administrator, 

Division of Scientific Review, National 

Institute of Child Health and Human 

Development, 6100 Executive Boulevard, 

Room 5b01, Bethesda, Md 20892–9304, (301) 

435–6680, skandasa@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: January 7, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–482 Filed 1–12–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, Childhood Obesity 

RFA HD–08–023. 

Date: February 6, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Michele C. HindiAlexander, PhD, Division of Scientific 

Review, National Institutes of Health, Eunice 

Kennedy Shriver, National Institute For 

Child Health & Development, 6100 Executive 

Boulevard, Room 5b01, Bethesda, MD 20812– 

7510, (301) 435–8382, 

hindialm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: January 7, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–483 Filed 1–12–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

SEPA SEP. 

Date: February 10, 2009. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Lee Warren Slice, PhD, 

Scientific Review Officer, Office of Review, 

National Center for Research Resources, 

Bethesda, MD 20892, 301–435–0965. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333, National Institutes of Health, 

HHS)